Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-15
2011-10-18
Lundgren, Jeffrey S (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S183000
Reexamination Certificate
active
08039459
ABSTRACT:
Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.
REFERENCES:
patent: 2232662 (1941-02-01), Hockenyos et al.
patent: 2456851 (1948-12-01), Woodward et al.
patent: 2466788 (1949-04-01), Howard et al.
patent: 2524094 (1950-10-01), Howard et al.
patent: 2541138 (1951-02-01), Howard et al.
patent: 2778772 (1957-01-01), Chen
patent: 2507925 (1960-05-01), Niederl et al.
patent: 3071509 (1963-01-01), O'Neill
patent: 3402039 (1968-09-01), Mussell et al.
patent: 4220781 (1980-09-01), Sanders et al.
patent: 4321387 (1982-03-01), Chavdarian et al.
patent: 5227391 (1993-07-01), Caldwell et al.
patent: 5691365 (1997-11-01), Crooks et al.
patent: 5846983 (1998-12-01), Sandborn et al.
patent: 5977144 (1999-11-01), Meyer et al.
patent: 5981549 (1999-11-01), Viner
patent: 6177429 (2001-01-01), Sit et al.
patent: 6610713 (2003-08-01), Tracey
patent: 6838471 (2005-01-01), Tracey
patent: 7067672 (2006-06-01), Comins et al.
patent: 7091357 (2006-08-01), Crooks et al.
patent: 7186277 (2007-03-01), Genet et al.
patent: 7501520 (2009-03-01), Comins et al.
patent: 2002/0160988 (2002-10-01), Amitai et al.
patent: 2004/0116519 (2004-06-01), Slatter
patent: 2004/0132737 (2004-07-01), Cormier et al.
patent: 2004/0132774 (2004-07-01), Heath
patent: 2004/0138289 (2004-07-01), Richards et al.
patent: 2004/0242569 (2004-12-01), Lennon
patent: 2004/0254373 (2004-12-01), Piotrowski et al.
patent: 2005/0019271 (2005-01-01), Bannister et al.
patent: 2005/0075323 (2005-04-01), Day et al.
patent: 2005/0130990 (2005-06-01), Cormier et al.
patent: 2009/0197921 (2009-08-01), Solis Herrera
patent: 2003/176240 (2003-06-01), None
patent: WO 96/15117 (1996-05-01), None
patent: WO 98/02188 (1998-01-01), None
patent: WO/99/21834 (1999-05-01), None
patent: WO 00/23062 (2000-04-01), None
patent: WO 01/15697 (2000-09-01), None
patent: WO 02/44176 (2002-06-01), None
patent: WO/02/076434 (2002-10-01), None
patent: WO/2006/005195 (2006-01-01), None
Adelowo-Imeokparia et al., Effects of Phenyl Ring Substituents on the Fungicidal Activity of O-Ethyl-n-Phenyl Carbamate, 2008, World Journal of Agricultural Sciences, vol. 4, No. 1, pp. 48-52.
Zanger et al., Remingtons Pharmaceutical Sciences, 1980, Chapter 27, pp. 420-435.
Thompson, D. C. et al.,Nicotinic Agonist Modulation of Feline Bronchomotor Tone, Clinical and Experimental Pharmacology and Physiology, vol. 17, No. 2, 1990, pp. 83-97.
Nielsen et al., 2000,Novel Potent Ligands for the Central Nicotinic Acetylcholine Receptor: Synthesis, Receptor Binding and 3D-QSAR Analysis, J. Med. Chem. 43, 2217-2226.
Romanelli et al., 2001,Structure-Affinity Relationships of a Unique Nicotinic Ligand: N1-Dimethyl-N4-phenylpiperazinium Iodide(DMPP), J. Med. Chem. 44, 3946-3955.
Toma et al., 2002,6-Chloropyridazin-3-yl Derivatives Active as Nicotinic Agents: Synthesis, Binding and Modeling Studies, J. Med. Chem. 45, 4011-4017.
Manetti et al., 1999,Hybridized and Isosteric Analogues of N1-Acetyl-N4-dimethyl-piperazinium Iodide(ADMP)and N1-Phenyl-N4-dimethyl-piperazinium Iodide(DMPP)with Central Nicotinic Action, Bioorganic & Medicinal Chemistry 7, 457-465.
Guandalini et al., 2005,Rigid analogs of DMPP as probes for the nicotinic receptors, IL Farmaco 60, 99-104.
Hanson, R. N., 1983,Preparation and Evaluation of Radioiodinated Phenylpiperazines as Adrenomedullary Imaging Agents, Int. J. Nucl. Med. Biol. 10(4): 219-222.
Zilber, A.P.,Respiratory Failure, Moscow “Meditsina”, 1989, pp. 288-289 and 295-296.
Berkow, R., Guide to Medicine, vol. 1, Moscow, “MIR”, 1997, pp. 450-451.
Reynold A. Panettieri, Jr.,Chronic Obstructive Lung Disease, Pathophysiology of Lungs, Moscow, “BINOM”, 2001, pp. 95-98.
Beleslin et al.,Central Nicotinic Receptors: Vomiting, Ear Twitching and Panting, Brain Res. Bull., vol. 11, No. 3, pp. 299-302, 1983.
Chemical Abstracts, Registry No. 54-77-3, 1971.
Flenley, D.C.,New drugs in respiratory disorders: I., Br. Med. J. (Clin. Res. Ed.), Mar. 12, 1983; 286(6368): 871-875.
Becker, A.B. et al.,The bronchodilator effects and pharmacokinetics of caffeine in asthma, N. Engl. J. Med., Mar. 22, 1984; 310(12); 743-6.
Baldassarre, Sandra et al.,Asthma attacks induced by low doses of celecoxib, aspirin and acetaminophen., J. Allergy and Clin. Immunol. 2006, 117(1): 215-217.
Etter, J.-F.,Cytisine for Smoking Cessation: A Literature Review and a Meta-analysis. Arch. Intern. Med., Aug. 14-28, 2006; 166(15): 1553-9.
Wang et al.,Interferon gamma Induction of Pulmonary Emphysema in the Adult Murine Lung, J. of Experimental Medicine, vol. 192, No. 11, Dec. 4, 2000, pp. 1587-1599 (XP-002257504).
Database WPI Derwent publication Ltd. London, GB; Abstract Only Considered, An 2000-291290 antiasthmatic drug as tablet and a method of tablet preparation & RU 2 127 123 A. (MOSC, Chem-Pharm PRODM Assoc) Mar. 10, 1999.
Fernandez, Elizabeth and Craviso, Gale L.,Protein Synthesis Blockade Differentially Affects the Degradation of Constitutive and Nicotinic Receptor-Induced Tyrosine Hydroxylase Protein Level in Isolated Bovine Chromaffin Cells, Journal of Neurochemistry, vol. 73, No. 1, 1999, pp. 169-178.
Cormier, Y. et al., 1985,Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers. Thorax 40(2): 138-142.
Cormier, Y. et al., 1988,Sequential bronchoalveolar lavage in experimental extrinsic allergic alveolitis. The influence of cigarette smoking, Am Rev Respir Dis 137(5): 1104-1109.
Cormier, Y. et al., 1998,Hypersensitivity pneumonitis in peat moss processing plant workers, Am J Respir. Crit Care Med 158(2): 412-417.
Gariepy, L. et al., 1989,Predictive value of bronchoalveolar lavage cells and serum precipitins in asymptomatic dairy farmers, Am Rev Respir Dis. 140(5):1386-1389.
Lawrence, E.G. et al., 1986,Cigarette smoking and bronchoalveolarT Cellpopulations in sarcoidosis, Ann N Y Acad Sci 465:657-664.
Valeyre D. et al., 1988,Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease, Thorax 43(7):516-524.
Rubin, D.T. and Hanuer, S. B., 2000,Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepetol 12(8):855-862.
Thomas, G.A. et al., 2000,Role of smoking in inflammatory bowel disease : implications for therapy. Postgrad Med J 76(895):273-279.
Guslandi, M., 1999,Nicotine Treatment for ulcerative colitis. Br. . Clin Pharmacol48(4):481-484.
Guslandi, M., 1999,Long-term effects of a single course of nicotine treatment in acute ulcerative colitis:remission maintenance in a 12-month follow-up study. Int J Colorectal Dis 14(4-5):261-262.
Rezvani, A.H. and Levin E.D., 2001,Cognitive effects of nicotine. Biol Psychiatry 49(3):258-267.
Kelton, M.C. et al., 2000,The effects of nicotine in Parkinson's disease. Brain Cogn 43(1-3):274-282.
Bertram, K.G., 1998,Basic and clinical pharmacology. Editions Appetton and Lange. Stanford. Connecticut.
Sekhon, H.S. et al., 1999,Prenatal nicotine increases pulmonary alpha 7 nicotinic receptor expression and alters feta lung development in monkeys. J Clin Invesst 103(5):637-647.
Maus, A.D. et al., 1998,Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors, Mol Pharmacol 54(5):779-788.
Shriver, S.P. et al., 2000,Sex-specific expression of gastrin-releasing peptide receptor .* relationship to smoking history and risk of lung cancer. J Nati Cancer Inst. 92(1):24-33.
Ferguson, D.G. et al., 2000,The alpha3 subtype of the nicotinic acetylcholine receptor is expressed in airway-related neurons of the nucleus tractus solitarius, but is not essential for reflex bronchoconstn'ction in ferrets. Neurosci Lett 287(2):141-145.
Singh, S.P. et al., 2000,Acute and chronic nicotine exposures modulate the immune system through different pathways. Toxicol Appl Pharmacol 164(1): 65-72.
Kalra, R. et al., 2000,Effects of cigar
Blanchet Marie-Renée
C. -Gaudreault René
Cormier Yvon
Israel-Assayag Evelyne
Labrie Philippe
Buchanan & Ingersoll & Rooney PC
Finn Meghan
Lundgren Jeffrey S
Universite Laval
LandOfFree
Nicotinic receptor agonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotinic receptor agonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinic receptor agonists for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4264971